HAP Trading’s Immunome IMNM Stock Holding History

HAP Trading’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-17,922	Closed	-$436K	–	2681
2021 Q3	$436K	Buy	+17,922	New	+$313K	0.01%	725

Other funds holding IMNM

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

PCM

Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HAP Trading's IMNM Position: Q4 2021 in Review

HAP Trading sold out of Immunome (IMNM) in Q4 2021, closing a stake of 17,922 shares — an estimated $436K sold.

HAP Trading first reported a position in IMNM in Q3 2021 and held it in 1 quarter. The position peaked at $436K in Q3 2021. 30 funds tracked by Wall St. Rank hold IMNM as of Q4 2021.

HAP Trading reported no remaining Immunome position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 17,922 Immunome shares in Q4 2021, an estimated $436K.
HAP Trading first reported a position in Immunome in Q3 2021 and held it in 1 quarter.
HAP Trading's Immunome position peaked at $436K in Q3 2021.
30 funds tracked by Wall St. Rank held Immunome as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.